Mood and behavioural disorders following traumatic brain injury: Clinical evaluation and pharmacological management

Brain Injury

Volumn 15, Issue 2, 2001, Pages 139-148

  Perino, C ^a   Rago, R ^a   Cicolin, A ^a   Torta, R ^a   Monaco, F ^a  

^a Presidio Ospedaliero Ausiliatrice   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CITALOPRAM;

ADULT; AFFECTIVE NEUROSIS; ANXIETY; ARTICLE; BEHAVIOR DISORDER; BRAIN INJURY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLASGOW COMA SCALE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MALE; PATIENT COMPLIANCE; PATIENT COUNSELING; PSYCHOMOTOR DISORDER; RATING SCALE; TREATMENT OUTCOME;

EID: 0035138219     PISSN: 02699052     EISSN: None     Source Type: Journal    
DOI: 10.1080/026990501458371     Document Type: Article

References (42)

1. Occurrence, severity, and outcomes of brain injuries
2. Late outcome of very severe blunt head trauma: A 10-15 year second follow-up
3. Psychiatric disorders and functional disability in outpatients with traumatic brain injuries
4. Social impairment and depression after traumatic brain injuries
5. The choice of antidepressants in depressed survivors of TBI
6. Control of depression with fluoxetine and anti-seizure medication in a brain-injured patient
7. Depression following traumatic brain injury
8. Moclobemide in the treatment of major depressive disorders following TBI
9. Paroxetine versus citalopram treatment of pathological crying after brain injury
10. The agitated brain-injured patient. Part 1: Definition, differential diagnosis and assessment
11. Are depressive symptoms specific for a depressed mood in TBI?
12. The brief psychiatric rating scale
13. La codification de l'impression clinicque globale
14. Citalopram: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness
15. Citalopram in the treatment of depression and other potential uses in psychiatry
16. CBZ: A comparison of the bioavailability of two preparations (200 and 400mg tablets)
17. Positive effects of CBZ on behavioral dyscontrol in borderline personality disorder
18. Successful treatment of episodic dyscontrol with CBZ
19. CBZ in agitation and aggressive behaviour following severe closed-head injury: Result of an open trial
20. Descriptive epidemiologic studies of head injury in the United States: 1974-1984
21. Depression after head injury: Do physical and cognitive sequelae have similar impact?
22. Factor structure of the Beck Depression Inventory in a sample of persons with TBI
23. Major depression in patients with closed head injuries
24. Enhanced emotional reactions in chronic head trauma patients
25. Relationship between personality disorders, social disturbances, and physical disability following TBI
26. Mood change following bilateral hemisphere brain injury
27. Depression in patients with acute T.B.I.
28. Mania after brain injury. A controlled study of causative factors
29. Comparison of mania and depression after brain injury: Causal factors
30. Frontal lobe injuries, violence, and aggression: A report of the Vietnam Head Injury Study
31. CFS transmitter metabolites and short-term outcome of patients in coma after head injury
32. Psychosocial and emotional sequelae of individuals with traumatic brain injury: A literature review and recommendations
33. A holistic approach to family assessment after brain injury
34. Psychotherapy after mild brain injury: Relationship to the nature and severity of subjective complaints
35. Weak, but complex pulsed magnetic fields may reduce depression following traumatic brain injury
36. Motivational deficits after brain injury: Effects of bromocriptine in 11 patients
37. Psychostimulants, dopamine agonists and amantadine
38. Depression after minor closed head injury: Role of dexamethasone suppression test and antidepressants
39. Treatment resistance of depression after head injury: A preliminary study of amitryptyline response
40. Diagnosis and neuroanatomical correlates of depression in brain-damaged patients
41. Fluoxetine: A new serotoninergically active antidepressant
42. Control of depression with fluoxetine and antiseizure medication in a brain injured patient